Former food and drug attorney and eight-year GPhA head will remain an advisor to the group through the transition period. The $8M-revenue Generic Pharmaceutical Association announced the resignation of President and CEO Kathleen Jaeger, effective June 30, about the time mega GPhA member Teva Pharmaceutical Industries is said to be departing the trade group. In a statement, GPhA board Chair Paul Bisaro announced Jaeger’s departure “with regret.” Jaeger “We are particularly grateful for her unprecedented success in broadening and strengthening our relationships with consumers, businesses, labor, state and federal agencies, pharmacy benefit managers and health plan… Read More